Literature DB >> 27139346

The burden of Herpes Zoster and its complications in Poland in according to the age.

Piotr Albrecht1, Marian Patrzałek2, Paweł Goryński3.   

Abstract

BACKGROUND: Incidence of shingles in different regions of the world ranged from 300 to 500/100,000 persons, and in the population older than 80 years of age reaches more than 1000/100,000. In the age group 50+ the incidence is enough high to be a serious medical and economic burden. Lack of details about the incidence and frequency of complications in Polish population let us too made an attempt to assess the scale of the problem, among others to the purpose of the evaluation of the legitimacy of implementing vaccination in the 50+ population.
METHODS: First, based on coming data from the Świętokrzyskie Province Division of the National Health Fund we judged the incidence of shingles in this province in 2013 in individual ancient groups and depending on detailed diagnoses and with the division into the basic health, clinic and hospital care. Second, based on gathered data through NIZP-PZH, we judged hospital morbidity connected with shingles in Poland in 2008-2012 years, in individual ancient groups.
RESULTS: Extrapolating the data from the Świętokrzyskie province we assess the incidence of shingles on average 338.8/100,000. She is tallest in the age group 50+ (614.3/100,000) and in this group also the most complications are being observed. Hospital morbidity in entire Poland showed in 2008-2012 years the frequency on average 4.93-5.42/100,000, in the group of 0-19 years; 0.10-1.50/100,000, in the group of 20-49 years; 4.9-5.42/100,000 and in the 50+ group--9.99-13.37/100,000.
CONCLUSIONS: (1) Shingles, especially in the 50+ age group, constitutes a serious health problem in Poland, being a cause of numerous advices in basic health care and at clinics in Poland, as well of numerous hospitalizations and dangerous complications. (2) It seems, that active immunization against shingles, especially of 50+ persons, would be a favourable solution from the individual, as well as public perspective.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27139346

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  3 in total

1.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

Review 2.  Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.

Authors:  Catherina X Pan; Michelle S Lee; Vinod E Nambudiri
Journal:  Ther Adv Vaccines Immunother       Date:  2022-03-21

Review 3.  Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.

Authors:  Molly Sauer; Prarthana Vasudevan; Ankita Meghani; Karuna Luthra; Cristina Garcia; Maria Deloria Knoll; Lois Privor-Dumm
Journal:  Vaccine       Date:  2021-02-19       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.